Merck CEO Ken Frazier gets 32% pay bump on strong Keytruda sales, cancer M&A

7th April 2020 Uncategorised 0

Merck & Co. previously eliminated a policy that required the retirement of its CEO at age 65 so that Ken Frazier can remain at the top job beyond 2019. Now that he’s celebrated that birthday, staying on looks even more attractive for Frazier, what with a 32% raise last year.

More: Merck CEO Ken Frazier gets 32% pay bump on strong Keytruda sales, cancer M&A
Source: fierce